» Articles » PMID: 39982392

Oridonin Preserves Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates Choroidal Neovascularization

Overview
Specialty Ophthalmology
Date 2025 Feb 21
PMID 39982392
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the role and mechanism of oridonin (ORI), a bioactive diterpenoid extracted from the Chinese herbal medicine Rabdosia rubescens, on the integrity of outer blood-retinal barrier (oBRB) during choroidal neovascularization (CNV).

Methods: ARPE-19 cells were exposed to hypoxia and treated with ORI. The expression of ZO-1 and occludin in the axis of TGFβR/SUV39H1/KLF11 was detected by WB, chromatin immunoprecipitation, luciferin report activity assay, and immunofluorescence assay (IF), and the effect of ORI on the barrier properties of ARPE-19 cells was studied. A laser-induced mouse CNV model was constructed, and ORI was administrated by oral gavage. IF on mouse choroid flat mounts was done to confirm the effect of ORI on BRB integrity. Indocyanine green angiography and IF on mouse retina-RPE-choroid flat mounts were performed to determine the effect of ORI on CNV formation and retinal function. Hematoxylin and eosin staining and TUNEL staining were carried out to appraise ocular and systemic cytotoxicity caused by ORI.

Results: ORI protected ARPE-19 cells from hypoxia-induced destruction of barrier properties and promoted the expression of ZO-1 and occludin by the TGFβR/SUV39H1/KLF11 axis, maintaining barrier properties of ARPE-19 cells with hypoxia. ORI improved BRB integrity during laser-induced CNV in mice and mitigated laser-induced CNV formation in mice without any ocular or systemic cytotoxicity (n = 4-5 in each group).

Conclusions: ORI ameliorates BRB integrity and subsequent formation of CNV via regulating the TGFβR/SUV39H1/KLF11 pathway in RPE cells.

References
1.
Zhang X, Zhu M, Xie L, Sun X, Xu J, Guo Y . Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization. J Ophthalmol. 2020; 2020:5905269. PMC: 7322600. DOI: 10.1155/2020/5905269. View

2.
Bu H, Shen F, Cui J . The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo. Onco Targets Ther. 2019; 12:7467-7476. PMC: 6752205. DOI: 10.2147/OTT.S220401. View

3.
Liu H, Wei W, Wang X, Guan X, Chen Q, Pu Z . miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1. Mol Med Rep. 2018; 18(6):5683-5692. DOI: 10.3892/mmr.2018.9611. View

4.
Liu S, Wang X, Sun X, Wei B, Jiang Z, Ouyang Y . Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1. Phytomedicine. 2024; 126:155426. DOI: 10.1016/j.phymed.2024.155426. View

5.
Dalmau-Mena I, Del Pino P, Pelaz B, Cuesta-Geijo M, Galindo I, Moros M . Nanoparticles engineered to bind cellular motors for efficient delivery. J Nanobiotechnology. 2018; 16(1):33. PMC: 5877387. DOI: 10.1186/s12951-018-0354-1. View